Quantum BioPharma Ltd.
QNTM
$6.30
$0.060.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.20M | -10.24M | -7.47M | -9.85M | -17.90M |
| Total Depreciation and Amortization | 490.50K | 499.90K | 525.90K | 1.50M | 2.51M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.92M | -260.30K | -1.83M | -776.30K | 2.93M |
| Change in Net Operating Assets | 9.76M | 3.10M | 3.63M | 1.08M | 1.64M |
| Cash from Operations | -6.88M | -6.89M | -5.14M | -8.05M | -10.83M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 31.80K | 31.80K | 31.80K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.50M | -2.75M | 414.70K | -323.50K | -301.40K |
| Cash from Investing | -1.50M | -2.75M | 446.50K | -291.70K | -269.60K |
| Total Debt Issued | 1.01M | 0.00 | 302.80K | 286.90K | -- |
| Total Debt Repaid | -63.70K | -59.20K | -109.40K | -149.50K | -189.10K |
| Issuance of Common Stock | 10.67M | 9.19M | 2.14M | 308.00K | 20.20K |
| Repurchase of Common Stock | -- | 0.00 | 0.00 | 0.00 | -2.96M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 11.62M | 9.13M | 2.33M | 445.60K | -3.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.24M | -513.70K | -2.36M | -7.89M | -14.22M |